https://www.live-feeds.com/feed/silicon-valley-s-longevity-drug-obsession-is-facing-its-first-real-reality-checkContinuously updated, source-cited coverage. https://www.live-feeds.com/feed/silicon-valley-s-longevity-drug-obsession-is-facing-its-first-real-reality-checkhttps://www.live-feeds.com/feed/silicon-valley-s-longevity-drug-obsession-is-facing-its-first-real-reality-check#u18756Tue, 30 Jun 2026 11:31:59 +0000The pursuit of longevity drugs in Silicon Valley is meeting significant skepticism as experts question the actual efficacy of current methods. Critics argue that misinformation and hype threaten the credibility of longevity science. Some researchers are now shifting focus from lifespan to biological resilience.Still unconfirmed:Isomorphic Labs raised $1.2 billion in a Series B round for AI drug discovery.Bryan Johnson used a transplant drug to attempt to live longer.Some experts suggest using organ-specific and trajectory-based biomarkers instead of a single consumer number.Misinformation and